These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-003945-41 Pharmacogenetics of GABAergic mechanisms of benefit and harm in epilepsy: : A prospective cohort study to determine the enviromental and genetic factors associated with response to clobazam. 2012-09-30 due-trials
Not reported 2005-000619-85 The relationship between genetic polymorphisms in the organic cation transporter genes and the pharmacokinetics and pharmacodynamics of metformin 2009-05-01 due-trials
Ongoing 2006-000087-83 EUROPAC2 trial to investigate the efficacy of ANTOX(vers) 1.2 and MGCT (magnesiocard) for the treatment of hereditary pancreatitis and idiopathic chronic pancreatitis. not-yet-due
Completed, but no date Terminated 2006-000576-33 Pilot Study to investigate the role of Glutamine in the early protective stress response bad-data
Not reported 2006-003425-81 Host genetic factors influencing drug disposition and response to HIV treatment 2011-10-20 due-trials
Not reported 2006-006076-38 The Liverpool HIV TDM Registry: Studying influences upon plasma HIV drug exposure 2015-12-30 due-trials
Ongoing 2007-004299-38 European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer. not-yet-due
Reported results 2007-006225-27 Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible (HOPON) 2018-05-15 due-trials
Reported results 2008-001137-99 CHANGE TO: A PILOT RANDOMISED STUDY TO COMPARE COMBINATION ANTIBIOTIC THERAPY (CIPROFLOXACIN AND DOXYCYCLINE) WITH STANDARD THERAPY (BUDESONIDE) IN THE TREATMENT OF ACTIVE CROHN'S DISEASE 2019-05-30 due-trials
Not reported Terminated 2008-002627-90 Intracellular boosting of HIV protease inhibitors through inhibition of transport - a novel strategy for potentiating HIV therapy 2012-02-29 due-trials
Ongoing 2008-004759-31 Purine-Alkylator Combination In Follicular lymphoma Immuno-Chemotherapy for Older patients: a phase III comparison of first-line R-CVP versus R-FC lite not-yet-due
Not reported Terminated 2008-006371-67 EFFECT OF THIENOPYRIDINE DERIVATIVE (CLOPIDOGREL) ON THE DISPOSITION OF EFAVIRENZ AND NEVIRAPINE IN HIV POSITIVE PATIENTS 2012-12-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012575-10 Trial of Optimal Therapy for Pseudomonas Eradication in Cystic Fibrosis 2018-04-10 bad-data
Reported results 2010-019575-29 Phase II trial of ofatumumab, dexamethasone and lenalidomide for high-risk CLL (NCRI CLL210) 2017-04-07 due-trials
Reported results 2010-021951-26 VIP: A prospective, phase II, double blinded, multicentre, randomised clinical trial comparing combination gemcitabine and vandetanib therapy with gemcitabine therapy alone in locally advanced or meta... 2018-09-05 due-trials
Ongoing 2010-023179-25 Effects of exenatide on appetite and ghrelin levels in patients with Prader-Willi Syndrome not-yet-due
Reported results 2010-023195-22 Randomised controlled open-label trial of TPF induction chemotherapy in the surgical management of locally advanced head and neck cancer (T = taxane, P = cisplatin, F = 5-fluorouracil) 2019-05-09 due-trials
Ongoing 2011-000919-22 RIAltO: A Randomised Investigation of Alternative Ofatumumab-containing regimens in less fit patients with CLL not-yet-due
Reported results 2012-000058-73 A multi-centre (UK) double-blind randomised parallel group placebo controlled trial to evaluate the efficacy, safety, and tolerability of Intravenous Immunoglobulin (IVIg) 0.5g/kg plus standard treatm... 2016-03-19 due-trials
Reported results 2012-000935-18 TAILoR – (TelmisArtan and InsuLin Resistance in HIV): A Dose-Ranging Phase II Randomised Open-Labelled Trial of Telmisartan as a strategy for the Reduction of Insulin Resistance in HIV-Positive Indivi... 2017-06-08 due-trials
Ongoing 2012-001884-64 A pragmatic randomised controlled trial comparing the effectiveness and cost effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of Standard And New Ant... not-yet-due
Reported results 2012-004025-24 A trial of de-escalation and stopping treatment in chronic myeloid leukaemia patients with excellent responses to tyrosine kinase inhibitor therapy DESTINY(De- Escalation and Stopping Treatment of Im... 2018-08-01 due-trials
Not reported 2012-005340-24 An international, multicentre, randomised, open-label, no-treatment controlled, parallel group, dose-response study to investigate the effect of once daily nitisinone on 24-hour urinary homogentisic a... 2013-12-13 due-trials
Not reported 2013-001633-41 An international, multicenter, randomized, evaluator-blinded, no-treatment controlled, parallel-group study to assess the efficacy and safety of once daily nitisinone in patients with alkaptonuria aft... 2019-02-15 due-trials
Ongoing 2013-003932-56 ESPAC-5F: European Study Group for Pancreatic Cancer - Trial 5F Four arm, prospective, multicentre, randomised feasibility trial of immediate surgery compared with neoadjuvant chemotherapies and neo... not-yet-due
Reported results 2013-005398-32 A randomised controlled trial of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction 2017-02-13 due-trials
Completed, report not yet due 2014-000988-41 A randomized, controlled multi-centre trial of 26 weeks of subcutaneous Liraglutide (a GLP1 receptor agonist), with or without continuous positive airway pressure (CPAP), in patients with Type 2 Diabe... 2019-10-10 not-yet-due
Reported results 2014-002188-13 Emergency Treatment with Levetiracetam or Phenytoin in Status Epilepticus in Children (EcLiPSE) – an open label randomised controlled trial 2018-05-21 due-trials
Reported results 2014-002387-32 Phase IIa, Randomised, Controlled, Open-Label Trial of Rosuvastatin for the Prevention of Aminoglycoside-Induced Kidney Toxicity in Children with Cystic Fibrosis 2017-12-13 due-trials
Ongoing 2014-004437-22 A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxel in metastatic Uveal Melanoma not-yet-due
Ongoing 2014-005390-36 Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of infliximab (IFX) verses alpha interferon (aIFN), with genotyping and metabolomic profiling, towards a strati... not-yet-due
Not reported Terminated 2015-003103-27 A proof of concept phase II study of Buparlisib in HER2 positive breast cancer with brain metastasis following HER2 directed monoclonal antibody therapy 2017-03-30 due-trials
Completed, reported early 2015-004502-42 SATURN: An exploration of the dynamic interaction between IL-17, IL-17 inhibition with (secukinumab) and neutrophils in psoriatic arthritis in vitro and ex vivo with exploratory study on the potential... 2019-09-16 not-yet-due
Ongoing 2015-005242-60 RESILIENT: RandomisEd, controlled, double blind Study to assess mechanistic effects of combination therapy of dapagliflozin with Exenatide QW versus dapagliflozin alone in obese (BMI>30 kg/m2) patient... not-yet-due
Reported results 2015-005342-63 Mindex: The efficacy and safety of very low dose dexamethasone used to facilitate the extubation of ventilator dependent preterm babies who are at high risk of bronchopulmonary dysplasia 2018-09-04 due-trials
Ongoing 2016-000543-13 A window of opportunity study to assess the biological effects of enobosarm in oestrogen receptor positive, androgen receptor positive early breast cancer not-yet-due
Ongoing 2016-004010-10 PETReA: Phase 3 evaluation of PET-guided, Response-Adapted therapy in patients with previously untreated, high tumour burden follicular lymphoma not-yet-due
Exempt Terminated 2017-001259-29 A PHASE 1B/2A STUDY TO ASSESS THE TOLERABILITY AND ADVERSE EFFECT PROFILE OF CYSTEAMINE (CYSTAGON) IN ADULTS AND CHILDREN WITH HOMOZYGOUS ΔF508 CYSTIC FIBROSIS, IN PATIENTS TAKING EPIGALLOCATECHIN-3-G... 2020-02-18 not-yet-due
Ongoing 2017-001521-41 A window of opportunity study to assess the biological effects of progesterone in premenopausal ER-positive, PgR-positive early breast cancer not-yet-due
Ongoing 2017-005033-22 In patients taking Protease Inhibitors does switching to a Bictegravir, Tenofovir Alafenamide and Emtricitabine combination, reduce cardiovascular risk: An open-label, randomised, serial CT pilot stud... not-yet-due
Ongoing 2018-000157-41 NEO21-RS: A phase II randomised study of the cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with oestrogen suppression therapy versus oestrogen suppression therapy alone as neoadjuva... not-yet-due
Ongoing 2018-000197-30 Sodium Valproate for Epigenetic Reprogramming in the Management of High Risk Oral Epithelial Dysplasia not-yet-due
Ongoing 2018-001169-18 The efficacy and mechanism of surfactant therapy for critically ill infants with bronchiolitis: The Bronchiolitis Endotracheal Surfactant Study. not-yet-due
No trial status on register 2018-001829-11 The Carboprost or Oxytocin Postpartum haemorrhage Effectiveness Study. Carboprost vs Oxytocin as the First Line Treatment of Primary Postpartum Haemorrhage; A phase IV, double-blind, double-dummy, ran... bad-data
Exempt 2020-001860-27 AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment not-yet-due